Brain stem cell implant trial offers new hope for Parkinson's
Disease control
Recruiting now
This early-stage trial tests a new treatment called RNDP-001, which involves transplanting dopamine-producing stem cells into the brains of 12 people with Parkinson's disease. The main goal is to see if the procedure is safe and tolerable. Researchers will also monitor changes in…
Phase: PHASE1, PHASE2 • Sponsor: Kenai Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC